Unlock instant, AI-driven research and patent intelligence for your innovation.

Non-viral episomal vector capable of controlling deletion and construction method thereof

A vector and sequence technology, applied in the field of genetic engineering, can solve problems such as increasing the risk of iPS transforming into cancer cells, and achieve the effect of high efficiency and simple operation process

Active Publication Date: 2014-04-23
CHINA AGRI UNIV
View PDF6 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Especially in the application of induced human embryonic stem cells (iPS) in cell therapy, studies have shown that the presence of exogenous induction factors (Oct4, sox2, cMyc, klf4) in iPS cells increases the ability of iPS to transform into cancer cells in cell therapy risk

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Non-viral episomal vector capable of controlling deletion and construction method thereof
  • Non-viral episomal vector capable of controlling deletion and construction method thereof
  • Non-viral episomal vector capable of controlling deletion and construction method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] The construction of embodiment 1 episomal vector

[0025] The vector construction steps are as follows, and the construction process is as follows figure 1 ;

[0026] 1. NheI and AgeI double-digest the pEPI-EGFP vector, insert the first loxp sequence, and obtain the intermediate vector 1,

[0027] 2. SalI and BmHI double-digest the intermediate vector 1, insert the second loxp sequence in the same direction to obtain the intermediate vector 2,

[0028] 3. PciI and NheI double digest the intermediate vector 2, delete the CMV promoter, insert the human EF1α promoter to replace the CMV promoter, and obtain the intermediate vector 3,

[0029] 4. Double digestion with BsaI and MluI, delete the neomycin resistance gene of the intermediate vector 2, insert the ampicillin resistance gene, and obtain the intermediate vector 4,

[0030] 5. AscI and SpeI double digestion pPB-CAG-TKiNeo vector to obtain the target fragment, insert AscI and SpeI double digestion intermediate vect...

Embodiment 2

[0031] Example 2 Cell Transfection and Controlled Deletion of Episomal Vectors

[0032] 1. Use the endotoxin-free plasmid extraction kit to extract the pEPI-EF1α-EGFP-CAG-TKiNeo plasmid, dissolve it in ultrapure water until the concentration reaches 1ug / ul, and carefully pipette 3ug of the plasmid and 5×10 6 After the cells were fully mixed, they were electrotransfected. After electrotransfection, the cells were plated on five 10cm cell culture dishes, and G418 was added to a concentration of 500ug / ml after 2 days of culture. After 10 days of screening, cell clones expressing green fluorescence could be seen, such as image 3 .

[0033] Because the expression of EGFP gene enhances green fluorescent protein, the cell clones can express green fluorescence, which proves that the pEPI-EF1α-EGFP-CAG-TKiNeo plasmid has been successfully transfected into the cells.

[0034] 2. Add TAT-Cre protein to a concentration of 400ng / ml and incubate for 24 hours, then add 0.2umol / Lganc to scr...

Embodiment 3

[0036] Example 3 Construction of Deletable Episomal Vectors for Inducing iPS

[0037] AscI digested pEPI-EF1α-EGFP-CAG-TkiNeo, recovered the linear vector from the gel, treated the linear vector with alkaline phosphatase, removed the 5’ phosphate of the linear vector, and used pSTEM as the template.

[0038] Primer F: aatGGCGCGCCTCGTGAGGCTCCGGTGCC;

[0039] With primer R: aatGGCGCGCCCTTACAATTTACGCCTTAAGATACATTG (the underlined part is the AscI restriction site, and the lowercase is the protective base that needs to be added for direct digestion of the PCR product), amplify to the target fragment, link with the linearized vector after AscI digestion, and transform, The target clone was obtained by screening, and the cloning vector map is as follows: Figure 4 shown.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a non-viral episomal vector capable of controlling deletion. The episomal vector is a controllable episomal vector formed by combining a Cre / loxP site-specific recombinase system with an S / MAR (chromosomal scaffold / matrixattachment region) component, wherein the S / MAR component roots in a human interferon beta gene. The episomal vector can artificially control a pEPI-1 vector to be thoroughly deleted from mammalian cells. The problem of safety of iPS (induced pluripotent stem) cells in cell therapy can be solved by applying the vector to preparation of the human iPS cells. Meanwhile, the vector can be also applied to research on production and transdifferentiation of iPS cells of other species, is simple in operation process and has high efficiency.

Description

technical field [0001] The invention relates to the field of genetic engineering, in particular to a non-viral episomal vector which can be regulated and deleted and a construction method thereof. Background technique [0002] Episomal vectors are a type of genetic material that is free from chromosomes and can stably parasitize in the nucleus. The main advantage of this kind of vector is that the exogenous gene can be expressed in the cell for a long time, without the need for the vector to be integrated into the cell genome, and avoids the risk of mutation of the endogenous gene caused by the random insertion of the vector. Scientists have been working for many years to develop episomal vectors that can replicate themselves in mammalian cells. Early self-replicating episomal vectors were mainly derived from human herpesvirus (EBV) and SV40 virus vectors. Their defect is the expression of trans-acting proteins. EBV vectors need to express herpes virus nuclear antigen 1 (EB...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N15/85C12N5/10
Inventor 李宁方锐畅飞赵馨张磊汤波王建武
Owner CHINA AGRI UNIV